Cullinan Therapeutics (CGEM) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.99
-0.84
-0.69
-0.54

Details

Expected EPS
-0.787929
Actual EPS
-0.69
Surprise EPS
0.1
Surprise Percent
+12.43%

Description

⁨Cullinan Therapeutics⁩ (⁦CGEM⁩) has reported earnings of ⁦-0.69⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts